Market View 27th July 2023

View on market: Volatility Prevails, Market is searching for better value

Asian equity futures were mixed after the Federal Reserve hiked interest rates to a 22-year high and indicated that further tightening would be “data dependent.” In the U.S., stocks rebounded from session lows, with the Dow Jones Industrial Average notching its 13th straight advance — the longest winning run since 1987. Another driver of trading Wednesday was the large batch of earnings reports. Meanwhile, Brent crude was below $83 a barrel and West Texas Intermediate was around the $79-mark. The yield on the 10-year U.S. bond was trading at 3.87% and Bitcoin was below 30,000-level. At 5:38 a.m., the GIFT Nifty, an early indicator of the Nifty 50 Index’s performance in India was unchanged at 19,990.

Economic Calendar:

• USD : GDP (QoQ) (Q2) on 27th July, 2023
• USD : Initial Jobless Claims on 27th July, 2023
• INR : FX Reserves, USD on 28th July, 2023
• INR : Infrastructure Output (YoY) (Jun) on 28th July, 2023

Brokerage Radar:

MS ON PNB: UW, TP Rs 55; PAT missed est – employee provisions stayed elevated & credit costs were higher than expected, but helped improve NPL coverage (76% vs. 71%). Impaired loans fell QoQ – a +ve; Continue to see better risk-reward at peer & prefer BOB & BOI

JEFFERIES ON BAJAJ FINANCE: Buy, TP raised to Rs 8830; 1Q profit rise of 32% YY strong & ahead of est. Delivering strong & broad-based AUM growth of 32%; Fall in NIM on expected lines; Some pressure on asset quality, led by rural mkts, lead to 10-15bps hike in credit cost guidance

JEFFERIES ON TECH MAHINDRA: U-P, TP cut to Rs 900; Revenues, down 4% QoQ, 440bps fall in EBIT margins & 39% QoQ decline in deal bookings disappointed.

Sharp 9% QoQ decline in CME vertical & single digit margins were key -ve surprises; Cut FY24-26 earnings est by 4-20%

International Markets

U.S & Europe:

Asian markets:

ADR Watch:

Commodities & Currency

FIIs & DIIs:

News Update:

Aurobindo Pharma: The company has set up a step-down subsidiary, Auro Pharma LLC, in Russia to pursue pharma business operations there. The drugmaker has proposed making an initial investment of around $10 million. As many as 100% of the shares of Auro Pharma LLC are held by Auro Active Pharma Private Limited.

Mahindra and Mahindra: The company acquired a 3.53% stake in RBL Bank. The stake was valued at Rs 417 crore. Mahindra may consider further investment subject to pricing, regulatory approvals, and required procedures. The circumstance will the company’s stake in RBL Bank will exceed 9.9%.

Poonawala Fincorp: The company completed the sale of 24.9 crore equity shares held in Poonawalla Housing Finance, an entity affiliated with TPG Global. Poonawalla Fincorp has received a post-tax amount of Rs 3,004 crore for the stake sale.

Rail Vikas Nigam: The government will sell up to 5.36% of its stake in Rail Vikas Nigam via the offer for sale route. This includes the green shoe option of selling a 1.96% stake. The offer opens Thursday for non-retail investors. The floor price for the OFS will be Rs 119 per share.

Marico: The company has acquired a 32.75% stake in Satiya Nutraceuticals on a fully diluted basis and has majority control overboard. It will buy the remaining 25.25% stake in tranches by May 2025.

Reliance Industries: Jio Financial Services, and BlackRock have signed joint venture pacts to foray into the asset management sector. The 50:50 joint venture, Jio BlackRock, will deliver tech-enabled access to affordable investment solutions. Both parties will initially invest $150 million (Rs 1230.19 crore) each in the joint venture.

IDFC First Bank: The lender will discuss and consider a proposal to raise funds in the next one year by issuing equity shares or other equity-linked securities.

Source: Moneycontrol, Bloomberg Quint, Investing 

Disclosure in pursuance of Section 19 of SEBI (RA) Regulation 2014

Elite Wealth Limited does/does not do business with companies covered in its research reports. Investors should be aware that the Elite Wealth Limited may/may not have a conflict of interest that could affect the objectivity of this report. Investors should consider this report as only information in making their investment decision and must exercise their own judgment before making any investment decision.

For analyst certification and other important disclosures, see the Disclosure Appendix, or go to www.elitewealth.in. Analysts employed by Elite Wealth Limited are registered/qualified as research analysts with SEBI in India.( SEBI Registration No.: INH100002300)

Disclosure Appendix

Analyst Certification (For Reports)

Kiran Tahlani, Elite Wealth Limited, kirantahlani@elitestock.com

The analyst(s) certify that all of the views expressed in this report accurately reflect my/our personal views about the subject company or companies and its or their securities. I/We also certify that no part of my compensation was, is or will be, directly or indirectly, related to the specific recommendations or views expressed in this report. Unless otherwise stated, the individuals listed on the cover page of this report are analysts in Elite Wealth Limited.

As to each individual report referenced herein, the primary research analyst(s) named within the report individually certify, with respect to each security or issuer that the analyst covered in the report, that:

(1) all of the views expressed in the report accurately reflect his or her personal views about any and all of the subject securities or issuers; and

(2) no part of any of the research analyst’s compensation was, is, or will be directly or indirectly related to the specific recommendations or views expressed in the report.

For individual analyst certifications, please refer to the disclosure section at the end of the attached individual notes.

Research Excerpts

This note may include excerpts from previously published research. For access to the full reports, including analyst certification and important disclosures, investment thesis, valuation methodology, and risks to rating and price targets, please visit www.elitewealth.in.

Company-Specific Disclosures

Important disclosures, including price charts, are available and all Elite Wealth Limited covered companies by visiting https://www.elitewealth.in, or e-mailing research@elitestock.com with your request. Elite Wealth Limited may screen companies based on Strategy, Technical, and Quantitative Research. For important disclosures for these companies, please e-mail research@elitestock.com.

Options related research:

If the information contained herein regards options related research, such information is available only to persons who have received the proper option risk disclosure documents. For a copy of the risk disclosure documents, please contact your Broker’s Representative or visit the OCC’s website at https://www.elitewealth.in

Other Disclosures

All research reports made available to clients are simultaneously available on our client websites. Not all research content is redistributed, e-mailed or made available to third-party aggregators. For all research reports available on a particular stock, please contact your respective broker’s sales person.

Ownership and material conflicts of interest Disclosure

Elite Wealth Limited policy prohibits its analysts, professionals reporting to analysts from owning securities of any company in the analyst’s area of coverage. Analyst compensation: Analysts are salary based permanent employees of Elite Wealth Limited. Analyst as officer or director: Elite Wealth Limited policy prohibits its analysts, persons reporting to analysts from serving as an officer, director, board member or employee of any company in the analyst’s area of coverage.

Country Specific Disclosures

India – For private circulation only, not for sale.

Legal Entities Disclosures

Mr. Ravinder Parkash Seth is the Managing Director of Elite Wealth  Ltd (EWL, henceforth), having its registered office at Casa Picasso, Golf Course Extension, Near Rajesh Pilot Chowk, Radha Swami, Sector-61, Gurgaon-122001 Haryana, is a SEBI registered Research Analyst and is regulated by Securities and Exchange Board of India. Telephone: 011-43035555, Facsimile: 011-22795783 and Website: www.elitewealth.in

EWL discloses all material information about itself including its business activity, disciplinary history, the terms and conditions on which it offers research report, details of associates and such other information as is necessary to take an investment decision, including the following:

1. Reports
2. a) EWL or his associate or his relative has no financial interest in the subject company and the nature of such financial interest;

(b) EWL or its associates or relatives, have no actual/beneficial ownership of one per cent. or more in the securities of the subject company, at the end of the month immediately preceding the date of publication of the research report or date of the public appearance;

(c) EWL or its associate or his relative, has no other material conflict of interest at the time of publication of the research report or at the time of public appearance;

2. Compensation

(a) EWL or its associates have not received any compensation from the subject company in the past twelve months;

(b) EWL or its associates have not managed or co-managed public offering of securities for the subject company in the past twelve months;

(c) EWL or its associates have not received any compensation for investment banking or merchant banking or brokerage services from the subject company in the past twelve months;

(d) EWL  or its associates have not received any compensation for products or services other than investment banking or merchant banking or brokerage services from the subject company in the past twelve months;

(e) EWL or its associates have not received any compensation or other benefits from the subject company or third party in connection with the research report.

3 In respect of Public Appearances
(a) EWL or its associates have not received any compensation from the subject company in the past twelve months;
(b) The subject company is not now or never a client during twelve months preceding the date of distribution of the research report and the types of services provided by EWL

Provided that research analyst or research entity shall not be required to make a disclosure as per sub-clauses (c), (d) and (e) of clause (ii) or sub-clauses (a) and (b) of clause (iii) to the extent such disclosure would reveal material non-public information regarding specific potential future investment banking or merchant banking or brokerage services transactions of the subject company.
(4) EWL or its proprietor has never served as an officer, director or employee of the subject company;
(5) EWL has never been engaged in market making activity for the subject company;
(6) EWL shall provide all other disclosures in research report and public appearance as specified by the Board under any other regulations.